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Abstract
Background: Increasing incidence of head and neck cancer (HNC) in young adults has
been reported. We aimed to compare the role of major risk factors and family history of
cancer in HNC in young adults and older patients.
Methods: We pooled data from 25 case-control studies and conducted separate analyses
for adults 45 years old (‘young adults’, 2010 cases and 4042 controls) and >45 years old
(‘older adults’, 17 700 cases and 22 704 controls). Using logistic regression with studies
treated as random effects, we estimated adjusted odds ratios (ORs) and 95% confidence
intervals (CIs).
Results: The young group of cases had a higher proportion of oral tongue cancer (16.0% in
women; 11.0% in men) and unspecified oral cavity / oropharynx cancer (16.2%; 11.1%) and a
lower proportion of larynx cancer (12.1%; 16.6%) than older adult cases. The proportions of
never smokers or never drinkers among female cases were higher than among male cases
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in both age groups. Positive associations with HNC and duration or pack-years of smoking
and drinking were similar across age groups. However, the attributable fractions (AFs) for
smoking and drinking were lower in young when compared with older adults (AFs for smok-
ing in young women, older women, young men and older men, respectively, ¼ 19.9% (95%
CI¼9.8%, 27.9%), 48.9% (46.6%, 50.8%), 46.2% (38.5%, 52.5%), 64.3% (62.2%, 66.4%); AFs
for drinking¼5.3% (11.2%, 18.0%), 20.0% (14.5%, 25.0%), 21.5% (5.0%, 34.9%) and 50.4%
(46.1%, 54.3%). A family history of early-onset cancer was associated with HNC risk in the
young [OR¼2.27 (95% CI¼ 1.26, 4.10)], but not in the older adults [OR¼1.10 (0.91, 1.31)].
The attributable fraction for family history of early-onset cancer was 23.2% (8.60% to 31.4%)
in young compared with 2.20% (2.41%, 5.80%) in older adults.
Conclusions: Differences in HNC aetiology according to age group may exist. The lower
AF of cigarette smoking and alcohol drinking in young adults may be due to the reduced
length of exposure due to the lower age. Other characteristics, such as those that are in-
herited, may play a more important role in HNC in young adults compared with older
adults.
Key words: Head and neck neoplasms, adult, smoking, alcohol drinking, diet
Introduction
Approximately 550000 new cases of head and neck cancer
(HNC) are diagnosed worldwide annually.1 Furthermore, an
increasing incidence of head and neck neoplasms among young
adults (YA) has been reported;2 in particular, reports indicate
an increase in tumours affecting the tongue and oropharynx
among YA in India,3 Europe,4 the USA5 and China.6
The aetiology of HNC in YA is still unclear. Some au-
thors proposed that HNC in YA might be a distinct subset
more related to genetic predisposition, or HPV infection,
than HNC in older adults7 because younger adults would
have a reduced length of exposure to major carcinogenic
factors,8 mainly tobacco and alcohol consumption and a
poor diet. Conversely, association studies specifically
assessing YA have found non-negligible associations be-
tween these risk factors and HNC.9,10 As these studies gen-
erally did not assess associations for older adults, it has not
been possible to know whether the risks of HNC
associated with its major risk factors are consistent across
age groups.
Because YA represent a minority of HNC, studies that
examined risk factors in this group comprised limited sam-
ples, which leads to imprecise results and does not allow for
stratification by cancer subsites or sex. In addition, studies
on HNC defined YA according to different age-group crite-
ria, i.e. arbitrary age cut-off points ranging from 3011 to 50
years,10 thus leading to limited comparability of results.
The use of pooled data from a large number of case-
control studies would provide increased statistical power for
the analysis of lifestyle characteristics and family history of
cancer associated with HNC in YA, thus allowing a rigorous
assessment of the hypothesis that HNC in YA constitutes an
aetiologically distinct subset. The International Head and
Neck Cancer Epidemiology (INHANCE) Consortium
[http://inhance.iarc.fr/] database provides a unique opportun-
ity to investigate the aetiology of HNC in YA.
Key Messages
• Positive associations of cigarette smoking and alcohol drinking with the risk of HNC were consistently lower in the
people aged 45 years or younger when compared with those over 45 years old.
• The attributable fractions of cigarette smoking and alcohol drinking for HNC in the people aged 45 years or less were
lower than in those over 45 years old, indicating roles of other risk factors in the HNC in young adults.
• The protective effect of a diet rich in fruits and vegetables on HNC was consistent across young and older people.
• Family history of cancer in young relatives was associated with an increased risk of HNC in young adults, but not in
the older group.
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Methods
Study population characteristics
The INHANCE consortium was established in 2004 to elu-
cidate the aetiology of HNC by providing opportunities
for pooled analyses of risk factors on a large number of
participants. This consortium pools epidemiological stud-
ies, mainly of case-control design, from many countries
and regions (Europe, North and South America, Asia and
Africa)—including studies from high-, medium- and
low-income countries.12 Version 1.3 of the INHANCE
Consortium pooled dataset comprised 26 case-control
studies from Europe, America and Asia.13-38 The
Germany-Saarland study from Europe did not include any
cases aged 45 years or younger and was thus excluded.
Subjects with missing data on age, sex and cancer subsite
were excluded (40 cases and 3 controls aged 45 years or
younger; and 156 cases and 23 controls older than 45
years). The YA group comprised 1910 cases and 4042 con-
trols aged 45 or younger. Results for cases (n¼ 16 694)
and controls (n¼22 772) older than 45 years of age (>45
years) were used for comparison.
Details of the 25 studies included in the analyses are
shown in Supplementary Table 1 (available as Supplementary
data at IJE online). Most of these were hospital-based case-
control studies, and in the majority of these studies, the con-
trol subjects were matched to cases with regard to age, sex
and additional characteristics (such as study centre, hospital
and race/ethnicity).
Cases were included in this analysis if the tumours had
been classified in the original study as invasive HNC accord-
ing to the International Classification of Diseases (ICD)
Oncology, Version 239 (ICD-O-2), the ICD-940 or the ICD-
10.41 ICD-10 codes were used to classify each tumour into
anatomical subsite categories: oral cavity (C00.3-C00.9,
C02.0-C02.3, C03.0, C03.1, C03.9, C04.0, C04.1, C04.8,
C04.9, C05.0, C05.8, C05.9, C06.0-C06.2, C06.8, C06.9),
oropharynx (C01.9, C02.4, C05.1, C05.2, C09.0, C09.1,
C09.8, C09.9, C10.0-C10.4, C10.8, C10.9), hypopharynx
(C12.9, C13.0-C13.2, C13.8 C13.9), oral-oropharynx-
hypopharynx not otherwise specified (C02.8, C02.9, C05.8,
C05.9, C14.0, C14.2, C14.8) and larynx (C32.0-C32.3,
C32.8, C32.9). Cancers of the salivary gland were excluded
from our analysis because their aetiological pattern differs
from that of other head and neck tumours.42
Our analysis included all histological types included in
the ICD codes considered in the study. For the Milan and
Aviano Italian multicentre studies and four centres in the
International Multicentre study (Bangalore, Madras, Sudan
and Trivandrum), no information on case histology was
available. Of the 1570 young head and neck cancer cases
for whom histological information was available, 88.2% of
the female cases and 94.5% of the male cases were squa-
mous cell carcinoma, whereas among the older cases, these
proportions were 94.0% and 97.1%, respectively.
Data collection and pooling
For all studies, interviews were conducted face to face by
trained interviewers. Written informed consent was ob-
tained from the study subjects, and the investigations were
approved by the institutional review boards at each of the
institutions involved. Questionnaires were collected from
all of the individual studies to assess data comparability
and the wording of interview questions. The data from in-
dividual studies were received with the personal identifiers
removed, and each data item was checked for illogical or
missing values. Queries were sent to investigators, and
inconsistencies were resolved.
The definition of ever or never cigarette smokers and
ever or never drinkers used in this study has been previ-
ously described in detail.42 Although questions regarding
history of cigarette smoking varied across studies, never
users of cigarettes, pipes and cigars did not exceed either 1
year of cigarette smoking or 100 cigarettes in a lifetime or
ever smoked ‘regularly’. Pack-years of cigarette smoking
were calculated by multiplying the number of packs
(defined as 20 cigarettes) per day by the number of years of
smoking.
Subjects were asked about the duration, frequency and
type of alcoholic beverages consumed (beer, wine, hard li-
quors and aperitifs). The definition of never drinkers also
varied throughout the studies, from 0 drinks in a lifetime
to <4 drinks per month. To address the different volume
specifications for each type of alcoholic beverage by study,
the number of drinks per day was calculated as the fre-
quency of consumption of each alcoholic beverage type
weighted by the relevant duration.
The assessment of diet has been described in detail pre-
viously.43 The data were collected using food frequency
questionnaires that obtained information about diet before
sick (Milan, Aviano, France, IARC multicentre studies), 10
years prior to interview (Seattle study), 5 years prior to
interview (Boston study), 2 years prior to interview (Italy
multicentre and Switzerland studies), 1 year prior to inter-
view (North Carolina, Rome, US multicentre and Western
Europe studies), within the 3 years before the interview
(Puerto Rico study), before having cancer (Los Angeles and
MSKCC studies), between 1980 and 1990 (Heidelberg
study) and the diet in the diagnosis (Central Europe study).
Briefly, four major food categories were examined: vege-
tables, fruits, animal products and others (cereals and
grains). Several food items and sub-food categories were
identified within each major food category. Centre-specific
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quartiles were used among the controls for food groups.
Of the 25 studies included, 21 collected data on diet. In the
Boston and Seattle study, data on diet were available only
for a subset of the subjects and those with no data were
not included in the analysis.
The definition of ‘family member with cancer’ was
described previously.44 Four categories of cancers in the
family were considered: (i) head and neck cancers, includ-
ing only cancers with the previously described topography;
(ii) other tobacco-related cancers [i.e. lung (C34), naso-
pharynx (C11), nasal cavity (C30), paranasal sinuses
(C31), oesophagus (C15), stomach (C16), pancreas (C25),
liver (C22), kidney (body and pelvis, C64), urinary bladder
(C67), uterine cervix (C53) and bone marrow (myeloid
leukaemia, C92)]; (iii) any cancer in relatives of any age;
(iv) any cancer in young relatives.
Statistical analysis
The associations between cigarette smoking, alcohol con-
sumption, diet, cancer in family members and HNC were
assessed by estimating the odds ratios (ORs) and 95%
confidence intervals (95% CIs) using mixed effects logistic
regression models, with study centres as random intercepts.
Respective ORs were calculated for each age group [45
years old (yo) and >45 yo] and sex with adjustments for
age, study, education, cigarette smoking (pack-years) and
alcohol consumption (drinks/day). Multivariate adjusted
models were further stratified according to cancer site (oral
cavity, oropharynx and larynx) and smoking status (never
smokers and ever smokers). The limited number of hypo-
pharynx cancer cases (n¼ 108) in YA 45 yo did not allow
stratification for that subsite. Linear trends in frequency,
duration and cumulative use of tobacco or alcohol and fre-
quency of food intake were assessed by p-values obtained
from modelling the continuous forms of these variables.
To test for differences in results according to age group,
we fitted models including subjects in both age groups
with adjustment for age, study, education, cigarette smok-
ing (pack-years) and alcohol consumption (drinks/day),
plus an interaction term between age group and each vari-
able of interest. p-Values for the interaction term were cal-
culated using likelihood ratio tests and used as suggestive
of differences or similarities in results according to age
group
The fraction (AF) of cases with HNC attributable to
cigarette smoking, alcohol drinking and family history of
cancer was estimated using the formula AF¼p(ec)
(OR 1)/OR, where p(ec) is the proportion exposed
among the case subjects.45
An influence analysis was performed by testing for vari-
ation in estimates according to the strata defined by data
collection period and geographical region of study. We
also performed analyses to determine whether any individ-
ual study’s data unduly influenced the results. Influence
analyses were performed using STATA SE11 using xtmelo-
git command.
We tested for between-study and between–study centre
heterogeneity by conducting a likelihood ratio test compar-
ing a multivariate logistic model, not mixedeffects models,
including the interaction terms between each study (other
than the reference study) with the variable of interest and a
model without the product terms, for the risk of HNC.
Results
Among cases, 10.7% were 45 yo. Compared with the
>45 yo group, YA with HNC had a higher proportion of
oral tongue cancer (16.0% in women and 11.0% in men)
and unspecified oral cavity/oropharynx cancer (16.2% in
women and 11.1% in men) and a lower proportion of
larynx cancer (12.1% in women and 16.6% in men).
With the exception of young female controls, higher pro-
portions of never smokers and never drinkers were
observed in young individuals as compared with the
older subjects. A higher proportion of individuals with a
higher education (Table 1) was found in YA cases and
controls of both sexes when compared with the older
group. Furthermore, across all of the age groups, the pro-
portions of cases with oral tongue cancer, never smokers
or never drinkers were higher among women than
among men.
The association with ever-smoking in YA was lower
than in older subjects (Table 2, Supplementary Table 2
available as Supplementary data at IJE online). This differ-
ence remained in the analysis stratified by cancer sub site
(Table 3), which also revealed substantially higher
associations for larynx cancer in all age groups when com-
pared with estimates for other subsites. The attributable
fraction for cigarette smoking on the risk of HNC was
19.9% (95% CI¼9.8%, 27.9%) in young women, 48.9%
(46.6%, 50.8%) in older women, 46.2% (38.5%, 52.5%)
in young men and 64.3% (62.2%, 66.4%) in older men. In
all age groups and sexes, the risk of HNC was directly
associated with increasing duration, frequency or cumula-
tive exposure to cigarette smoking, with a dose-response
effect observed in cumulative cigarette consumption. ORs
for both duration and cumulative strata of smoking were
similar across age groups among men. Among women,
lower ORs were found for smoking frequency in YA com-
pared with the older group. Across all age groups, higher
Ors were found for men than for women (Table 2,
Supplementary Table 2 available as Supplementary data at
IJE online).
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The association with ever drinking in YA was weaker
than in the older group. However, risks according to strata
of frequency, duration and cumulative consumption were
similar across age groups, with the exception of the highest
category of frequency of intake (5 drinks/day), which
showed stronger associations in older than in young individ-
uals (Table 4, Supplementary Table 3 available as
Supplementary data at IJE online). Associations with alcohol
Table 3. Tobacco smoking and the risk of head and neck cancer by age group, separately according to cancer sub-
site. International Head and Neck Cancer Epidemiology Consortium
Subsite 45 yo >45 yo
Cases Controls OR (95% CI) Cases Controls OR (95% CI)
Oral cavity cancer
Tobacco smokinga
Never 220 1793 1.00 1009 8463 1.00
Ever 519 2207 1.91 (1.53, 2.38) 3825 13 513 2.18 (1.99, 2.39)
Missing 2 12 – – 17 25 – –
Pack-yearsa
Never smoker 220 1793 1.00 1009 8463 1.00
>0 to 10 93 894 1.11 (0.83, 1.49) 293 277 0.92 (0.79, 1.08)
>10 to 20 117 569 1.87 (1.39, 2.51) 361 2312 1.39 (1.20, 1.61)
>20 to 30 129 397 2.80 (2.06, 3.81) 528 2136 2.22 (1.94, 2.54)
>30 to 40 71 136 4.09 (2.75, 6.07) 677 1998 2.82 (2.47, 3.21)
>40 to 50 39 78 3.73 (2.28, 6.11) 554 1413 3.25 (2.82, 3.74)
>50 64 92 4.99 (3.22, 7.73) 1360 2663 3.49 (3.10, 3.92)
Missing 8 53 – – 69 241 – –
p-trend <0.001 <0.001
Oropharynx cancer
Tobacco smokinga
Never 133 1793 1.00 71 8463 1.00
Ever 414 2207 1.86 (1.47, 2.37) 3755 13 513 2.77 (2.50, 3.08)
Missing 1 12 – – 06 25 –
Pack –yearsa
Never smoker 133 1793 1.00 571 8463 1.00
>0 to 10 66 894 1.01 (0.73, 1.40) 317 277 1.36 (1.16, 1.58)
>10 to 20 90 569 1.81 (1.31, 2.50) 371 2312 1.81 (1.56, 2.10)
>20 to 30 113 397 2.69 (1.94, 3.72) 503 2136 2.56 (2.22, 2.95)
>30 to 40 60 136 4.55 (3.02, 6.87) 641 1998 3.39 (2.95, 3.89)
>40 to 50 37 78 4.09 (2.48, 6.73) 481 1413 3.69 (3.17, 4.29)
>50 45 92 3.99 (2.46, 6.48) 1396 2663 4.96 (4.37, 5.62)
Missing 4 53 – – 52 241 – –
p-trend <0.001 <0.001
Larynx cancer
Tobacco smokinga
Never 23 1371 1.00 243 7048 1.00
Ever 285 184 6.34 (3.98, 10.1) 4237 11 448 8.31 (7.21, 9.58)
Missing 2 9 – – 28 20 – –
Pack-yearsa
Never smoker 23 1371 1.00 243 7048 1.00
>0 to 10 40 759 2.86 (1.65, 4.97) 229 2441 2.41 (1.98, 2.93)
>10 to 20 48 481 5.16 (2.99, 8.91) 359 2054 4.35 (3.63, 5.21)
>20 to 30 84 319 12.8 (7.51, 22.0) 581 1825 8.23 (6.94, 9.76)
>30 to 40 43 109 18.6 (10.1, 30.3) 784 1718 11.15 (9.44, 13.2)
>40 to 50 32 68 20.9 (10.8, 40.8) 684 1199 12.97 (10.9, 15.4)
>50 33 69 20.2 (10.4, 39.8) 1535 2010 18.03 (15.3, 21.1)
Missing 7 48 – – 93 221 – –
p-trend <0.001 <0.001
aORs adjusted on sex, age, study, education level and drink/day of alcohol (study centre as random intercept).
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intake remained in the specific assessment of ever smokers,
whereas in never smokers associations were observed only
among older men (Supplementary Table 4, Supplementary
Table 5, available as Supplementary data at IJE online).
With respect to the duration of alcohol intake, differences by
sex were observed: duration was not associated with HNC
risk in young women, whereas direct associations were
observed among young men, older women and older men
(Table 4). The attributable fraction for alcohol drinking on
the risk of HNC was 5.3% (95% CI¼11.2%, 18.0%) in
young women, 20.0% (95%CI¼ 14.5%, 25.0%) in older
women, 21.5% (5.0%, 34.9%) in young men and 50.4%
(46.1%, 54.3%) in older men.
The analysis that included all HNC cases and controls
indicated that the frequency of drinking, rather than the dur-
ation, played a more important role in HNC development.
Considering this finding, we used stratified analyses to as-
sess the role of drinking status (ever/never drinker) and the
frequency of alcohol intake by cancer subsite (Table 5).
Positive associations were comparable for alcohol consump-
tion across age groups in all cancer subsites. In addition,
Ors for alcohol consumption were higher for oropharynx
than for cancers of other subsites.
The frequency of fruit and vegetable intake was inversely
associated with HNC risk in both age groups (Table 6,
Supplementary Table 6 available as Supplementary data at
IJE online). This inverse association remained in the strati-
fied analysis by sex, cancer subsite and smoking status
(Supplementary Table 7, Supplementary Table 8, available
as Supplementary data at IJE online). No association was
observed between meat and cereal consumption and HNC
risk in YA (Table 6). Conversely, positive associations were
found for the highest quartile of intake of meat products in
older men and the highest quartile of intake of cereals in
women.
Family history of any cancer was directly associated with
HNC only among the older group (Table 5, Supplementary
Table 9 available as Supplementary data at IJE online).
Borderline associations were found for family history of
smoking-related cancers in the >45 age group, in which a
family history of HNC was also positively associated with
HNC risk. A family history of early-onset cancer was associ-
ated with HNC risk only in YA (Table 7). Among YA never
smokers, a family history of any cancer was inversely associ-
ated with HNC whereas in YA ever smokers, a positive as-
sociation was found. The attributable fraction for family
history of early-onset cancer on the risk of HNC was 23.2%
(95% CI¼ 8.6%, 31.4%) in young and 2.2% (2.41%,
5.8%) in older adults.
Between-study heterogeneity was detected. ORs for to-
bacco, alcohol, diet and family history of cancer were simi-
lar in sensitivity analysis when excluding one study at time
(results not shown) or according to the recruitment period
of study (studies conducted before 2000 vs studies con-
ducted after 2000). In addition, when cases with missing
information on histology were excluded, the results did not
significantly change (results not shown). As an exception,
estimates for cigarette smoking (ever vs never smokers) in
older women and men were higher in earlier studies when
compared with later studies (results not shown). The geo-
graphical region of study also partially explained the ef-
fects of cigarette smoking and alcohol drinking. The risks
for ever vs never cigarette smokers, as well as for ever vs
never alcohol drinkers, were higher in Europe and Latin
America in comparison with North America and Asia in
both age groups and sexes (results not shown). Estimates
for family history of cancer on HNC risk were higher in
Latin America in comparison with North America and
Europe. Conversely, inverse associations for family history
of cancer and HNC risk were found among the young in
Asia (results not shown).
Discussion
To our knowledge, this is the largest study evaluating the
role of the major risk factors for HNC in YA (persons aged
45 years or less) as well as to compare risks in YA and older
patients. The large sample size allowed us to elucidate any
differences in the role of risk factors in HNC in YA accord-
ing to age group, sex and cancer subsites. Our results sup-
ported the differences in the characteristics of cases aged 45
years or younger compared with those aged >45 years: YA
comprised a lower proportion of drinkers and/or smokers
and were more likely to have been diagnosed with oral and/
or oropharynx cancer, as previously reported. Moreover, a
higher proportion of oral tongue cancer was observed in YA
compared with the older cases, as well as in women com-
pared with men in all age groups. In addition, we found evi-
dence that the importance of cigarette smoking in relation
to HNC in YA may be limited by the lesser duration of ex-
posure due to young age. We also found evidence that alco-
hol consumption is a risk factor for HNC in YA; however, a
more intense association with heavy drinking was observed
for the older group. Our results also indicate that the inverse
association with fruit and vegetable intake is similar among
young and older populations. Furthermore, aggregation of
early malignancy diagnosis in the family was associated
with HNC risk only among YA.
The characteristics of YA with HNC in terms of expos-
ure to risk factors and cancer subsites are consistent with
those described in previous studies performed in the
USA,46,47 the UK,48 Italy,9 Sri Lanka,49 Brazil50,51 and
India.52 All of these studies reported a higher percentage of
women, never smokers, never drinkers and oral cavity
178 International Journal of Epidemiology, 2015, Vol. 44, No. 1
cancer among YA with HNC compared with studies that
included patients of all age groups. We also found a higher
proportion of oral cavity cancer (especially oral tongue
cancer) among the young cases and this proportion was
higher among women. This finding agrees with those of
previous studies which reported increasing rates for oral
cavity tumours (especially oral tongue cancer) in individ-
uals younger than 40 years of age in India,3 Europe,4 the
USA5,53 and China.6
Association studies on HNC risk factors among YA have
been performed in several countries9,10,49,50,54-68. Most of
the studies only included young patients with
oral49-51,57-61,63,64 and pharyngeal cancers,9,65 whereas
some other studies included only laryngeal cancer patients68
and some included all HNC subsites.10,54–56,62,66,67,69 The
age cut-off for the ‘young adult’ group varied across the
studies, including 30 years,56,57 35 years,58 40
years,49–51,54,55,59,62,63,67–69 45 years9,60,61,64–66 and 50
Table 5. Alcohol drinking and the risk of head and neck cancer by age group, separately according to cancer sub-
site. International Head and Neck Cancer Epidemiology Consortium
Subsite 45 years old >45 years old
Case Control OR (95% CI) Case Control OR (95% CI)
Oral cavity cancer
Alcohol drinkinga
Never 183 207 1.00 911 5830 1.00
Ever 557 2758 1.24 (0.97, 1.57) 3919 16 119 1.61 (1.46, 1.79)
Missing 1 47 21
Frequency (drinks/day)a
Never drinker 183 1207 1.00 912 5836 1.00
>0 to <1 131 1144 0.79 (0.59, 1.07) 900 6026 0.99 (0.88, 1.12)
1 to <3 126 705 1.39 (1.01, 1.90) 842 4745 1.34 (1.18, 1.52)
3 to <5 62 323 1.49 (1.01, 2.20) 524 2101 2.12 (1.83, 2.46)
5 196 464 2.77 (2.01, 3.83) 1380 2630 3.71 (3.25, 4.23)
Missing 43 169 – – 293 663 – –
p-trend <0.001 <0.001
Oropharynx cancer
Alcohol drinkinga
Never 83 207 1.00 447 5830 1.00
Ever 464 2758 1.66 (1.25, 2.21) 3875 16 781 2.16 (1.92, 2.44)
Missing 1 47 – – 10 52 – –
Frequency (drinks/day)a
Never drinker 83 207 1.00 447 5836 1.00
>0 to <1 135 1144 1.24 (0.90, 1.72) 823 6026 1.28 (1.11, 1.47)
1 to <3 99 705 1.55 (1.09, 2.21) 819 4745 1.83 (1.59, 2.11)
3 to <5 43 323 1.40 (0.98, 2.41) 580 2101 3.13 (2.67, 3.66)
5 171 464 4.30 (2.98, 6.20) 1452 2630 5.68 (4.91, 6.55)
Missing 17 169 – – 211 663 – –
p-trend <0.001 <0.001
Larynx cancer
Alcohol drinkinga
Never 38 97 1.00 465 4698 1.00
Ever 268 2270 1.25 (0.83, 1.87) 3999 13 781 1.90 (1.41, 1.80)
Missing 4 7 – – 44 37 – –
Frequency (drinks/day)a
Never drinker 38 947 1.00 465 4704 1.00
>0 to <1 5 889 0.89 (0.55, 1.44) 762 4726 1.03 (0.89, 1.19)
1 to <3 61 600 1.21 (0.75, 1.95) 961 4308 1.29 (1.12, 1.48)
3 to <5 40 296 1.33 (0.77, 2.27) 641 2016 1.76 (1.50, 2.06)
5 105 411 1.81 (1.13, 2.90) 1496 2372 2.82 (2.40, 3.25)
Missing 11 81 – – 183 390 – –
p-trend <0.001 <0.001
aORs adjusted on sex, age, study, education level and pack-years of cigarette smoking (study centre as random intercept).
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years.10 Most analyses of studies with an age cut-off of 45
or 50 yearsfound associations with diet, tobacco and
alcohol.9,10,61,64–66 Regarding studies with an age cut-off of
35 or 40 years, some of these studies reported that HNC in
young cases was less strongly associated with drinking and
smoking,49–51,57,58,62,67,69 whereas others reported stronger
associations.59,69 The largest case group in studies that
included persons only aged 45 years or younger com-
prised137 patients.9
The risk of HNC associated with the cumulative con-
sumption of tobacco in YA found in the present study is in
agreement with previous studies conducted in Europe.2,9,10
No differences by age were observed with the strata of
duration and cumulative consumption of cigarettes, thus
supporting the hypothesis that the carcinogenic effect of
cigarette smoking does not depend on age if the level of
exposure is the same among young and older individuals.
In addition, the weaker associations for ever smoking
observed in YA as compared with the older group support
the hypothesis that the relationship between cigarette
smoking and head and neck carcinogenesis in YA may be
limited by a reduced length of exposure due to young
age.8,64 Thus, this observation would indicate a more
important role of other, unknown risk factors for HNC in
YA.8,57 Consistent with this hypothesis are also the lower
attributable fractions found for tobacco in YA in compari-
son with the older group.
Frequent alcohol consumption was associated with
HNC in young subjects and this finding has been reported
by other investigators.9,10,64 Kmietowicz70 suggested that
the increasing incidence of mouth cancer among young
British subjects may be linked to a modified alcohol
consumption pattern of higher frequency of alcohol con-
sumption at very young ages. Although our data did not
allow the assessment of ‘binge’ drinking, which is an alco-
hol intake pattern that has been associated with other life-
style-associated cancers,71 our findings regarding the
frequency of alcohol intake suggest the impact of factors
other than alcohol consumption on early head and neck
carcinogenesis, as the associations with ever drinking were
lower in YA than in the older group. Furthermore, drink-
ing status in ever smokers presented a higher HNC risk in
every age stratum, which supports the hypothesis that alco-
hol intake increases the carcinogenic effect of cigarette
smoking in all age groups.72
Consistent with other studies, our results suggest that a
high frequency of fruit and vegetable consumption is asso-
ciated with a reduced risk of HNC in YA. Previous studies
also found associations between a diet rich in fruits and
vegetables and a reduced risk of HNC in all ages,43 par-
ticularly in YA.9,10,64,73 In contrast to the weaker relation-
ship between tobacco or alcohol and HNC risk at young
ages than older ages, the inverse association with fruit and
vegetable consumption did not seem to be influenced by
the length of exposure; the same observation was reported
by Llewellyn et al.64
In our study, 20% of young cases had at least one fam-
ily member with a history of any cancer. Although this pro-
portion is similar to that observed in a previous study in
Canada, which included only patients under 41 years of
age,62 other studies found higher proportions, such as 66%
for cases under 46 years of age in England48 and 55% for
Table 7. Family history of cancer and the risk of head and neck cancer according to age subgroups.
International Head and Neck Cancer Epidemiology Consortium
History 45 yo >45 yo
Case Control OR (95% CI) Case Control OR (95% CI)
Family history of cancer (all sites)a
No 1075 1075 1.00 1.00 7535 10 455 1.00
Yes 308 308 1.15 (0.95, 1.39) 3387 5516 1.13 (1.05, 1.21)
Family history of smoking-related cancera
No 1041 1041 1.00 7743 10 342 1.00
Yes 120 120 1.16 (0.87, 1.56) 1472 2093 1.80 (0.99, 1.18)
Family history of head and neck cancera
No 1149 2442 1.00 9068 12 937 1.00
Yes 32 35 1.45 (0.81, 2.60) 476 323 1.63 (1.37, 1.93)
Family history of cancer in young relativesa
No 72 196 1.00 1346 2800 1.00
Yes 51 75 2.27 (1.26, 4.10) 439 642 1.10 (0.91, 1.31)
aORs adjusted by sex, race, age, education level, pack-years of cigarette smoking and drink day of alcohol (study centre as random
intercept).
International Journal of Epidemiology, 2015, Vol. 44, No. 1 181
cases under 40 years of age53 in the USA. Cancer aggrega-
tion seemed to play different roles in HNC carcinogenesis
in YA compared with older adults in our study. Similarly
to previous findings by Negri et al.44 in a study including
all age groups (that also used data from the INHANCE
Consortium to assess the role of family history of cancer),
family history of any cancer at any age was associated with
HNC in individuals aged >45 years. However, no associ-
ation was observed among individuals aged 45 years,
which contrasts with the results of other studies that specif-
ically assessed young patients.50,54 Caution is needed when
interpreting this result, as the probability of having a fam-
ily member with cancer may be higher for older than for
young people. Older people are more likely to have older
relatives, and since cancer risk generally increases with
age, the chances of having a relative with cancer would
be higher for older persons. In contrast, direct associations
with family history of cancer in YA were observed in
ever smokers, whereas the association was inverse in
never smokers. Further studies are needed to explain
whether these results may be driven by a possible familial
aggregation of risk factors or by some gene-environment
interaction.
A novel finding of our study is the association between
the aggregation of early-onset family history of cancer and
HNC risk in YA. Similar results have been reported for
lung cancer,74,75 but the biological mechanisms that ex-
plain this association are still unclear. In addition, caution
is needed in interpreting this result because only four stud-
ies were included and a very low percentage of patients
(10%) from these studies had available relevant informa-
tion. Thus, the possibility of information bias resulting
from the higher proportion of missing information should
be considered.
Our study has some limitations. Recall bias is a poten-
tial limitation that is difficult to overcome in case-control
studies. Another limitation is that we were unable to
examine HPV infection as a risk factor or adjust for it to
determine whether the association between cigarette
smoking and alcohol consumption in oropharyngeal can-
cer according to sex could be related to HPV infection
status.
The major strength of our study was the large sample
size of young HNC patients and controls, which allowed
us to explore heterogeneity in risk by sex and cancer sub-
site in more detail than previously performed. We also
used data from older patients as a basis for comparison
and found evidence for differences in HNC aetiology ac-
cording to major risk factors. Our results support the pub-
lic health efforts to decrease the exposure to major risk
factors for HNC in the population regardless of age.
However, investigations of the role of other risk factors,
such as HPV and inherited characteristics, in HNC in this
age group are warranted.
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